Novavax, Inc.Equity-NMS: NVAX
Equity-NMS: NVAX
$15.87
-0.57
(3:16 pm IST)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$15.87
Open
$15.87
Today’s high
$16.57
Today’s low
$15.57
52W low
$3.53
52W high
$23.86
1Y
94.13%
5Y
28.41%
PE
-4.23
EPS (TTM)
-5.41
Shares O/S
140.40M
Market cap
2.31B
Insights
NVAX is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Novavax, Inc.

Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine).

The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response. .


FAQs

Can I buy Novavax, Inc. shares in India?
How to buy Novavax, Inc. shares in India?
What is the share price of Novavax, Inc.?
What is the Market Capitalization of Novavax, Inc.?
What is the PE ratio of Novavax, Inc.?
Is Novavax, Inc. a good stock to buy?
In which sector / industry does Novavax, Inc. operate?